Advisor Group Holdings, Inc. Mei Pharma, Inc. Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.22 - $8.4 $1,450 - $55,364	-6,591 Reduced 92.95%	500 $0
Q3 2022 Nov 14, 2022	BUY	$0.41 - $8.8 $756 - $16,227	1,844 Added 35.14%	7,091 $3,000
Q2 2022 Aug 10, 2022	BUY	$0.42 - $0.65 $1,221 - $1,890	2,908 Added 124.33%	5,247 $3,000
Q1 2022 May 04, 2022	SELL	$0.54 - $2.74 $266 - $1,350	-493 Reduced 17.41%	2,339 $1,000
Q3 2021 Nov 05, 2021	BUY	$2.52 - $2.99 $1,156 - $1,372	459 Added 19.34%	2,832 $7,000
Q2 2021 Aug 02, 2021	BUY	$2.6 - $3.65 $2,483 - $3,485	955 Added 67.35%	2,373 $6,000
Q1 2021 May 13, 2021	BUY	$2.73 - $4.5 $3,871 - $6,381	1,418 New	1,418 $5,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $385M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.